Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank Artha Graha Internasional Tbk. (INPC) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Bank Artha Graha Internasional Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Bank Artha Graha Internasional Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Bank Artha Graha Internasional Tbk. trades at Rp139 (market cap 2.8T, 1.38M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 4.5× Bank Artha Graha Internasional Tbk.'s market cap, and Bank Artha Graha Internasional Tbk. is more actively traded (1.38M versus 235.2K). Which is the better fit depends on your goals.

INPCTSPC
Market Cap
2.8T12.58T
Volume
1.38M235.2K
Lot
13.82K2.35K
Turnover
193.17M649.94M
Average Price
139.752,763.37
Value
193.17M649.94M
Indicative Equilibrium Price
1392,780
Indicative Equilibrium Volume
1619

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INPC
View details
TSPC
View details

About Bank Artha Graha Internasional Tbk.

PT Bank Artha Graha Internasional Tbk (“the Bank”) initially was established under the name of PT Inter-Pacific Financial Corporation based on notarial deed No. 12 dated September 7, 1973 of Bagijo, SH, substitute notary of Eliza Pondaag, SH, Notary in Jakarta. PT Bank Inter Pacific, Tbk is a joint venture bank that for the previous period of 20 years operated as Non Bank Financial Institution (NBFI) and went public in August 1990.

Read more on INPC

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC